Viewing Study NCT03495206


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2026-01-13 @ 6:31 AM
Study NCT ID: NCT03495206
Status: UNKNOWN
Last Update Posted: 2020-02-17
First Post: 2018-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
Sponsor: Yantai YenePharma Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Y-2-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators